Buscar
BioCardia Inc
BCDAAñadir a la lista de seguimiento
1.231USD
-0.009-0.72%
Horarios del mercado （ET）Cotizaciones retrasadas 15 min
13.24MCap. mercado
PérdidaP/E TTM
Más Datos de BioCardia Inc Compañía
BioCardia, Inc. is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases. It is advancing two cell therapy platforms derived from bone marrow, such as CardiAMP autologous mononuclear cell therapy platform is being advanced for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia. Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being advanced as a cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome. Its CardiAMP autologous and CardiALLO allogeneic cell therapies are the Company’s biotherapeutic platforms with three clinical stage product candidates in development. These therapies are enabled by its Helix biotherapeutic delivery and Morph vascular navigation product platforms.
Información de BioCardia Inc
Símbolo de cotizaciónBCDA
Nombre de la empresaBioCardia Inc
Fecha de salida a bolsaNov 13, 1996
Director ejecutivoAltman (Peter)
Número de empleados17
Tipo de seguridadOrdinary Share
Fin del año fiscalNov 13
Dirección320 Soquel Way
CiudadSUNNYVALE
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal94085
Teléfono16502260123
Sitio Webhttps://www.biocardia.com/
Símbolo de cotizaciónBCDA
Fecha de salida a bolsaNov 13, 1996
Director ejecutivoAltman (Peter)
Ejecutivos de BioCardia Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Simon H. Stertzer, M.D.
Dr. Simon H. Stertzer, M.D.
Independent Director
Independent Director
764.27K
+14.29%
Mr. Andrew Scott Blank
Mr. Andrew Scott Blank
Independent Chairman of the Board
Independent Chairman of the Board
638.74K
+0.42%
Dr. Peter Altman, Ph.D.
Dr. Peter Altman, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
299.97K
+2.43%
Mr. Jim Allen
Mr. Jim Allen
Independent Director
Independent Director
109.66K
--
Mr. David Mcclung
Mr. David Mcclung
Chief Financial Officer
Chief Financial Officer
76.89K
--
Dr. Richard M. Krasno, Ph.D.
Dr. Richard M. Krasno, Ph.D.
Independent Director
Independent Director
16.27K
--
Mr. Bill Facteau
Mr. Bill Facteau
Independent Director
Independent Director
13.12K
--
Mr. Jay M. Moyes, CPA
Mr. Jay M. Moyes, CPA
Independent Director
Independent Director
3.62K
--
Mr. Edward Gillis
Mr. Edward Gillis
Senior Vice President - Devices
Senior Vice President - Devices
--
--
Mr. Marvin L. Slosman
Mr. Marvin L. Slosman
Independent Director
Independent Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Simon H. Stertzer, M.D.
Dr. Simon H. Stertzer, M.D.
Independent Director
Independent Director
764.27K
+14.29%
Mr. Andrew Scott Blank
Mr. Andrew Scott Blank
Independent Chairman of the Board
Independent Chairman of the Board
638.74K
+0.42%
Dr. Peter Altman, Ph.D.
Dr. Peter Altman, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
299.97K
+2.43%
Mr. Jim Allen
Mr. Jim Allen
Independent Director
Independent Director
109.66K
--
Mr. David Mcclung
Mr. David Mcclung
Chief Financial Officer
Chief Financial Officer
76.89K
--
Dr. Richard M. Krasno, Ph.D.
Dr. Richard M. Krasno, Ph.D.
Independent Director
Independent Director
16.27K
--
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de BioCardia Inc?
Los cinco principales accionistas de BioCardia Inc son: Dr. Simon H. Stertzer, M.D.
¿Cuántas instituciones poseen acciones de BioCardia Inc (BCDA)?
A fecha de 2026Q1, 39 instituciones poseen acciones de BioCardia Inc, con un valor de mercado combinado de aproximadamente 737.78K, lo que representa el 6.74% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en 268093.00.